Lorenzo Maria Rovesti

Disclosure information not submitted.

Presentation(s):

• MP07-13: Medications mostly associated with haematuria: assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries

  Friday, May 13, 2022
  10:30 AM – 11:45 AM

• MP58-01: Is MRI and fusion biopsies necessary in patients with PSA levels >10 ng/ml?

  Monday, May 16, 2022
  1:00 PM – 2:15 PM